YES!Delft

LYLA

Founders
Kas Hogeboom (Co-Founder & Business Developer), Ernst van der Wal (Co-Founder & Hardware Designer), Bauke van Gameren (Co-Founder & Software Architect)
Founded in
2025

Sectors

  • Health & Pharma

Introduction

Targeted Alpha Therapy (TAT) & Targeted Beta Therapy (TBT) treat metastatic cancer by carrying radioactive loads (e.g. Actinium-225) to destroy the tumor from inside the body. Yet, current quality control causes time and money-consuming delays for the hospitals and patient health risks. We solve this by providing swift and accurate quality control solutions that enable the full potential of radiopharmaceuticals in de battle against cancer.

Visit website

To top
1
2
3
4
5
6
7
8
9
10
11
12